| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.47 | 0.09 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.22 | 0.5 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.18 | 0.0009 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | -0.18 | 0.02 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.16 | 0.007 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.04 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.14 | 0.02 |
| mRNA | palmostatin B | CTRPv2 | pan-cancer | AAC | -0.12 | 0.006 |
| mRNA | GNF-2 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.1 |